May serve as a molecular marker for or play a role in the malignant progression of glioblastomas. Expressed predominantly in brain and weakly in heart and lung. Expression is reduced or undetectable in cultured glioma cells, primary glioblastoma cells and malignant glioblastoma tumors. Product of a dubious CDS prediction.